LeMaitre Q3 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Lemaitre Vascular (LMAT) Misses Q3 EPS by 2c
October 28, 2021 4:24 PM EDTLemaitre Vascular (NASDAQ: LMAT) reported Q3 EPS of $0.30, $0.02 worse than the analyst estimate of $0.32. Revenue for the quarter came in at $38.4 million versus the consensus estimate of $39.05 million.
For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.
... More